-BIOCHEMISTRY-
PREMIUM THESIS TOPICS

Since Its Almost Impossible or at least very difficult to change the thesis topics once its approved by institutional ethical committee. Its therefor important that you choose a good as well as easy to do thesis. There is no point in unnecessarily choosing a complex thesis topic and getting frustrated for the rest of your residency. You can discuss with me before choosing any thesis topic and i will advice you accordingly.

Biochemical Parameters in Diabetes Mellitus

List of premium Biochemistry thesis topics to choose from. You can take our advice before selecting any thesis topics as once approved by ethical committee its difficult to change thesis topics later.

This page covers type 2 diabetes biochemistry thesis topics across glycaemic control and insulin resistance, dyslipidaemia and cardiovascular risk, diabetic kidney disease, liver function, inflammation and oxidative stress, and vitamin, micronutrient and thyroid parameters. The topics are intended for MD Biochemistry candidates and can generally be completed within one thesis period using routinely available patients, clinical records and laboratory investigations. The list also supports candidates searching for type 2 diabetes biochemistry research topics, while a structured diabetes biochemistry protocol or diabetes biochemistry synopsis can be developed once the primary biochemical endpoint, patient definition and assay methods are fixed.

Last reviewed and updated: August 2026

📌 Updated for 2026–2027 MD Biochemistry admissions

The list was reviewed for practical diabetes-related laboratory endpoints, interpretable comparison groups and common sources of bias in biochemical studies of type 2 diabetes mellitus.

Most topics can be completed with glucose, HbA1c, insulin, lipid profile, renal and liver biochemistry, urine albumin, electrolytes and selected vitamin, inflammatory or oxidative-stress assays.
Glucose clamps, continuous glucose monitoring, advanced metabolomics and specialised molecular assays are not required for the majority of these projects.
Publication potential is strongest where diabetes duration, treatment, obesity, renal function, fasting state and the definition of glycaemic control are prespecified rather than handled after data collection.

Generate a protocol from any topic below

Select Generate Protocol → beside any title and receive a submission-ready document built around that topic, containing all eighteen components:

Introduction / Synopsis
Research Question
Aim of the Study
Primary Objective
Secondary Objectives
Materials and Methods
Inclusion Criteria
Exclusion Criteria
Sample Size Calculation
Methodology
Statistical Analysis
Ethical Considerations
Review of Literature
References
Gantt Chart / Study Timeline
Patient Information Sheet
Consent Form
Data Collection Form

Already know your thesis title?

Skip the list and generate the full glycaemic control, insulin resistance and glucose metabolism protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Glycemic Control, Insulin Resistance and Glucose Metabolism

A cross-sectional study of fasting plasma glucose, postprandial plasma glucose, and glycated hemoglobin and their interrelationship in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of fasting plasma glucose, postprandial plasma glucose, and glycated hemoglobin in patients with newly diagnosed and previously diagnosed type 2 diabetes mellitus.
An observational study of the association between glycated hemoglobin and fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus.
A cross-sectional study of fasting insulin levels and insulin resistance in patients with type 2 diabetes mellitus and their association with glycemic control.
A comparative study of fasting insulin and insulin resistance indices in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of insulin resistance and its association with body mass index, waist circumference, and lipid profile in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of insulin resistance in obese and non-obese patients with type 2 diabetes mellitus.
A cross-sectional study of glycated hemoglobin and its association with body mass index and waist-to-height ratio in patients with type 2 diabetes mellitus.
An observational study of the association of glycated hemoglobin with age, duration of diabetes, and anthropometric parameters in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of biochemical parameters of glycemic control in patients with type 2 diabetes mellitus with and without central obesity.
A cross-sectional study of fructosamine levels and their association with glycated hemoglobin and fasting plasma glucose in patients with type 2 diabetes mellitus.
A comparative study of serum fructosamine levels in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
A cross-sectional study of the relationship between serum fructosamine and postprandial plasma glucose in patients with type 2 diabetes mellitus.
An observational study of the association between fasting plasma glucose and glycated hemoglobin across different age groups in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of glycemic parameters in male and female patients with type 2 diabetes mellitus.
A cross-sectional study of the association between glycated hemoglobin and duration of diabetes in patients with type 2 diabetes mellitus.
A comparative observational study of glycated hemoglobin levels in patients with type 2 diabetes mellitus with and without obesity.
A cross-sectional study of fasting insulin, fasting plasma glucose, and insulin resistance and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of fasting insulin levels in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
A cross-sectional study of the triglyceride-glucose index as a surrogate marker of insulin resistance in patients with type 2 diabetes mellitus.
A comparative study of the triglyceride-glucose index in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of the triglyceride-glucose index and its association with glycated hemoglobin and anthropometric parameters in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of the triglyceride-glucose index in obese and non-obese patients with type 2 diabetes mellitus.
An observational study of the association between fasting plasma glucose, glycated hemoglobin, and triglyceride-glucose index in patients with type 2 diabetes mellitus.
A cross-sectional study of the triglyceride-glucose index and its association with lipid abnormalities in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of glycemic parameters and insulin resistance indices in patients with type 2 diabetes mellitus with and without metabolic syndrome.
A cross-sectional study of glycated hemoglobin and its association with components of metabolic syndrome in patients with type 2 diabetes mellitus.
An observational study of the association between glycemic control and systolic and diastolic blood pressure in patients with type 2 diabetes mellitus.
A comparative study of glycemic parameters in hypertensive and normotensive patients with type 2 diabetes mellitus.
A cross-sectional study of the relationship between glycated hemoglobin, insulin resistance, and central obesity in patients with type 2 diabetes mellitus.

Lipid Profile, Dyslipidaemia and Cardiovascular Risk Parameters

A cross-sectional study of serum lipid profile and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum lipid profile in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
An observational study of the association between serum triglycerides and glycated hemoglobin in patients with type 2 diabetes mellitus.
A cross-sectional study of low-density lipoprotein cholesterol and its association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of high-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of total cholesterol to high-density lipoprotein cholesterol ratio and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with adequate and poor glycemic control.
A cross-sectional study of triglyceride to high-density lipoprotein cholesterol ratio and its association with insulin resistance in patients with type 2 diabetes mellitus.
An observational study of the association between lipid ratios and glycemic parameters in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of lipid ratios in obese and non-obese patients with type 2 diabetes mellitus.
A cross-sectional study of atherogenic index of plasma and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of atherogenic index of plasma in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of atherogenic index of plasma and its association with body mass index and waist circumference in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of atherogenic index of plasma in male and female patients with type 2 diabetes mellitus.
An observational study of the association between atherogenic index of plasma and duration of diabetes in patients with type 2 diabetes mellitus.
A cross-sectional study of non-high-density lipoprotein cholesterol and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of non-high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus with and without hypertension.
A cross-sectional study of remnant cholesterol and its association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of calculated remnant cholesterol in patients with type 2 diabetes mellitus and apparently healthy individuals.
An observational study of the association between remnant cholesterol and triglyceride-glucose index in patients with type 2 diabetes mellitus.
A cross-sectional study of serum apolipoprotein A1 and apolipoprotein B levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative observational study of conventional lipid profile and apolipoprotein-based cardiovascular risk markers in patients with type 2 diabetes mellitus.
A cross-sectional study of serum lipoprotein(a) levels and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of serum lipoprotein(a) levels in patients with type 2 diabetes mellitus with and without hypertension.
A cross-sectional study of serum uric acid and lipid parameters as biochemical correlates of cardiovascular risk in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of lipid profile and atherogenic indices in patients with type 2 diabetes mellitus with and without obesity.
An observational study of the association between dyslipidemia and renal function parameters in patients with type 2 diabetes mellitus.
A cross-sectional study of conventional lipid parameters, lipid ratios, and atherogenic index of plasma and their relationship with glycemic control in patients with type 2 diabetes mellitus.

Renal Function, Electrolytes, Minerals and Diabetic Kidney Disease

A cross-sectional study of serum creatinine, estimated glomerular filtration rate, and urinary albumin-to-creatinine ratio and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of renal function parameters in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
An observational study of the association between serum creatinine and glycated hemoglobin in patients with type 2 diabetes mellitus.
A cross-sectional study of estimated glomerular filtration rate and its association with duration of diabetes and glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of renal function parameters in hypertensive and normotensive patients with type 2 diabetes mellitus.
A cross-sectional study of urinary albumin-to-creatinine ratio and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of glycemic and lipid parameters in patients with type 2 diabetes mellitus with and without albuminuria.
An observational study of the association between urinary albumin-to-creatinine ratio and lipid abnormalities in patients with type 2 diabetes mellitus.
A cross-sectional study of urinary albumin-to-creatinine ratio and its association with serum uric acid in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of urinary albumin excretion in obese and non-obese patients with type 2 diabetes mellitus.
A cross-sectional study of serum cystatin C and its association with glycated hemoglobin and estimated glomerular filtration rate in patients with type 2 diabetes mellitus.
A comparative study of serum cystatin C and serum creatinine as biochemical markers of renal dysfunction in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum cystatin C levels in patients with type 2 diabetes mellitus with and without albuminuria.
An observational study of the association between serum cystatin C and duration of diabetes in patients with type 2 diabetes mellitus.
A cross-sectional study of serum uric acid and its association with renal function parameters in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum uric acid levels in patients with type 2 diabetes mellitus with and without albuminuria.
A cross-sectional study of serum uric acid and its association with glycated hemoglobin and lipid profile in patients with type 2 diabetes mellitus.
A comparative study of serum uric acid levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
An observational study of the association between hyperuricemia and estimated glomerular filtration rate in patients with type 2 diabetes mellitus.
A cross-sectional study of serum sodium and potassium levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum sodium and potassium levels in patients with adequate and poor glycemic control.
A cross-sectional study of serum magnesium levels and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of serum magnesium levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A comparative cross-sectional study of serum magnesium levels in patients with type 2 diabetes mellitus with and without albuminuria.
An observational study of the association between serum magnesium and lipid parameters in patients with type 2 diabetes mellitus.
A cross-sectional study of serum calcium, phosphorus, and magnesium and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum calcium and phosphorus levels in patients with type 2 diabetes mellitus with and without renal dysfunction.
A cross-sectional study of serum calcium-phosphorus product and its association with renal function in patients with type 2 diabetes mellitus.
An observational study of the association between serum electrolytes, renal function, and glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of renal function, serum electrolytes, and mineral profile in patients with type 2 diabetes mellitus with adequate and poor glycemic control.

Liver Function, Inflammation and Oxidative Stress

A cross-sectional study of liver function parameters and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum alanine aminotransferase and aspartate aminotransferase levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
An observational study of the association between serum aminotransferases and glycemic control in patients with type 2 diabetes mellitus.
A cross-sectional study of gamma-glutamyl transferase levels and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of gamma-glutamyl transferase levels in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
A cross-sectional study of gamma-glutamyl transferase and its association with lipid profile in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of liver function parameters in obese and non-obese patients with type 2 diabetes mellitus.
An observational study of the association between liver enzyme levels and insulin resistance in patients with type 2 diabetes mellitus.
A cross-sectional study of serum albumin and total protein levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum albumin levels in patients with type 2 diabetes mellitus with and without albuminuria.
A cross-sectional study of high-sensitivity C-reactive protein and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of high-sensitivity C-reactive protein levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A comparative cross-sectional study of high-sensitivity C-reactive protein levels in patients with adequate and poor glycemic control.
A cross-sectional study of high-sensitivity C-reactive protein and its association with lipid profile and atherogenic indices in patients with type 2 diabetes mellitus.
An observational study of the association between high-sensitivity C-reactive protein and body mass index in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of high-sensitivity C-reactive protein in obese and non-obese patients with type 2 diabetes mellitus.
A cross-sectional study of serum ferritin and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of serum ferritin levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A comparative cross-sectional study of serum ferritin levels in patients with adequate and poor glycemic control.
An observational study of the association between serum ferritin and insulin resistance in patients with type 2 diabetes mellitus.
A cross-sectional study of serum ferritin and lipid profile as biochemical correlates of metabolic dysfunction in patients with type 2 diabetes mellitus.
A cross-sectional study of serum malondialdehyde as a marker of oxidative stress and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of serum malondialdehyde levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A comparative cross-sectional study of serum malondialdehyde levels in patients with adequate and poor glycemic control.
A cross-sectional study of total antioxidant capacity and its association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of total antioxidant capacity in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of serum uric acid as an endogenous antioxidant and its relationship with oxidative stress markers in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of oxidative stress markers in patients with type 2 diabetes mellitus with and without obesity.
An observational study of the association between oxidative stress markers and lipid abnormalities in patients with type 2 diabetes mellitus.
A cross-sectional study of high-sensitivity C-reactive protein, serum ferritin, and oxidative stress markers and their association with glycemic control in patients with type 2 diabetes mellitus.

Vitamins, Micronutrients, Thyroid and Other Biochemical Parameters

A cross-sectional study of serum vitamin D levels and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative study of serum vitamin D levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A comparative cross-sectional study of serum vitamin D levels in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
A cross-sectional study of serum vitamin D and its association with insulin resistance in patients with type 2 diabetes mellitus.
An observational study of the association between serum vitamin D levels and lipid profile in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum vitamin D levels in obese and non-obese patients with type 2 diabetes mellitus.
A cross-sectional study of serum vitamin D, calcium, and phosphorus levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of serum vitamin B12 levels in patients with type 2 diabetes mellitus receiving metformin and those not receiving metformin.
A cross-sectional study of serum vitamin B12 levels and their association with duration of metformin therapy in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum vitamin B12 levels in patients receiving different daily doses of metformin for type 2 diabetes mellitus.
An observational study of the association between serum vitamin B12 levels and glycated hemoglobin in patients with type 2 diabetes mellitus receiving metformin.
A cross-sectional study of serum vitamin B12 and homocysteine levels in patients with type 2 diabetes mellitus receiving metformin.
A comparative study of serum homocysteine levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of serum homocysteine and its association with glycated hemoglobin and lipid profile in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum homocysteine levels in patients with type 2 diabetes mellitus with and without albuminuria.
A cross-sectional study of serum zinc levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of serum zinc levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of serum zinc levels and their association with lipid profile in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum zinc levels in patients with adequate and poor glycemic control.
A cross-sectional study of serum copper and zinc levels and copper-to-zinc ratio in patients with type 2 diabetes mellitus.
A comparative study of serum copper-to-zinc ratio in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of serum copper-to-zinc ratio and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A cross-sectional study of thyroid-stimulating hormone and thyroid hormone levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of thyroid function parameters in patients with type 2 diabetes mellitus with adequate and poor glycemic control.
An observational study of the association between thyroid-stimulating hormone and lipid abnormalities in patients with type 2 diabetes mellitus.
A comparative study of glycemic and lipid parameters in patients with type 2 diabetes mellitus with and without biochemical thyroid dysfunction.
A cross-sectional study of serum thyroid-stimulating hormone and its association with body mass index and glycated hemoglobin in patients with type 2 diabetes mellitus.
A cross-sectional study of serum lactate dehydrogenase levels and their association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of serum lactate dehydrogenase levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of serum vitamin D, vitamin B12, magnesium, and zinc levels and their association with glycated hemoglobin in patients with type 2 diabetes mellitus.

Alongside glycaemic control, insulin resistance and glucose metabolism protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Glycaemic control, insulin resistance and glucose metabolism research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the glycaemic control, insulin resistance and glucose metabolism research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the glycaemic control, insulin resistance and glucose metabolism research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a glycaemic control, insulin resistance and glucose metabolism research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — QCHP and Hamad Medical Corporation. A glycaemic control, insulin resistance and glucose metabolism IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning glycaemic control, insulin resistance and glucose metabolism research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the glycaemic control, insulin resistance and glucose metabolism research proposal is the document assessed at the start of it.

Kuwait — KIMS. A glycaemic control, insulin resistance and glucose metabolism study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the glycaemic control, insulin resistance and glucose metabolism proposal follows the same structure throughout.

Generate a glycaemic control, insulin resistance and glucose metabolism research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A glycaemic control, insulin resistance and glucose metabolism dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full glycaemic control, insulin resistance and glucose metabolism research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

These are written individually, by a medical doctor, with no artificial intelligence generation and no plagiarism, and revised until the supervisor accepts them.

Enquire about a glycaemic control, insulin resistance and glucose metabolism PhD or MMed proposal →

🔥 Trending research areas in type 2 diabetes biochemistry for 2026–27

Triglyceride-glucose and atherogenic indices: routinely available measurements are increasingly combined into surrogate markers of insulin resistance and cardiovascular risk.
Early diabetic kidney dysfunction: albuminuria, cystatin C and creatinine-based eGFR can identify different aspects of renal involvement and create useful comparative research questions.
Metformin and vitamin B12: treatment duration and dose provide clinically relevant exposures for studies of vitamin B12 and homocysteine in type 2 diabetes.
Inflammatory and oxidative-stress phenotypes: hs-CRP, ferritin, malondialdehyde and antioxidant measures are being related to glycaemic control, but require careful handling of obesity, infection and renal dysfunction as confounders.

Protocol and synopsis guidance

What a type 2 diabetes biochemistry protocol must contain

Define diabetes and glycaemic control before recruitment. The protocol should state how type 2 diabetes mellitus is diagnosed, whether newly diagnosed and treated patients are analysed together, and the exact HbA1c or glucose criterion used for adequate and poor control. Treatment class, diabetes duration and recent therapeutic changes should be recorded because they can influence nearly every biochemical endpoint in the study.

Fix the metabolic sampling conditions. Fasting insulin, fasting glucose, triglycerides and derived insulin-resistance indices require a defined fasting period. Postprandial glucose requires a reproducible time anchor. The specimen type, assay platform, timing and formula for HOMA-IR, triglyceride-glucose index or other calculated indices should be stated in advance.

Do not assume HbA1c is an error-free reference for glycaemia. Anaemia, haemoglobin variants, altered red-cell survival, recent transfusion and chronic kidney disease can shift HbA1c independently of glucose. Studies correlating other biomarkers with HbA1c should measure, exclude or account for these factors rather than automatically treating discordance as poor assay performance.

Type 2 diabetes biochemistry synopsis versus type 2 diabetes biochemistry protocol

A synopsis is the concise academic plan submitted for departmental or university approval, whereas the protocol is the operational document used to conduct the study. For type 2 diabetes biochemistry, the protocol should specify diagnostic criteria, glycaemic-control categories, fasting requirements, medication exposure, diabetes duration, assay methods, sample timing and the exact calculation of derived metabolic or lipid indices.

The distinction matters because apparently simple comparisons can be confounded by treatment and disease duration. For example, patients with poor glycaemic control may differ from well-controlled patients in insulin use, obesity, renal function or duration of diabetes. The synopsis can state the broad comparison, but the protocol should define how these variables will be measured and handled analytically.

Sample size and statistical analysis

Base sample size on one primary endpoint. A comparison of HbA1c, magnesium or vitamin B12 between two groups requires assumptions about the expected difference and variability, whereas a correlation study requires an expected correlation coefficient. Studies of albuminuria or another categorical outcome need an expected difference in proportions or an appropriate regression-based calculation.

Preserve continuous biochemical information where possible. HbA1c, eGFR, triglyceride-glucose index, hs-CRP and micronutrient concentrations often contain more information as continuous variables than after arbitrary categorisation. When categories such as adequate and poor control are required, their cut-offs should be defined before examining the data.

Plan for confounding and skewed distributions. Insulin, triglycerides, urine albumin-to-creatinine ratio, hs-CRP, ferritin and oxidative-stress markers may be markedly skewed. Transformation or non-parametric methods may be appropriate. Multivariable models should consider age, sex, obesity, diabetes duration, medications, renal function and hypertension when these factors can influence both the exposure and biochemical outcome.

Frequently Asked Questions – Glycaemic Control, Insulin Resistance And Glucose Metabolism (2026–27)

1. How do I choose a feasible type 2 diabetes biochemistry thesis topic in 2026?

Start with a biochemical endpoint that is measured reliably in the laboratory and a patient group available in sufficient numbers. A focused study using HbA1c, lipid profile, renal markers, electrolytes, vitamin B12 or another routinely performed assay is generally more feasible than a project requiring several expensive specialised biomarkers. The strongest topic has one primary question and clearly defined diabetes, treatment and comparison groups.

2. Which study designs are accepted for type 2 diabetes biochemistry research?

Cross-sectional, comparative cross-sectional, case-control, cohort and retrospective record-based designs can all be appropriate. Cross-sectional studies suit biochemical associations, comparative studies suit predefined groups such as adequate versus poor glycaemic control, and cohort designs are preferable when change over time or temporal sequence is important. The design should follow the research question rather than being selected only because it is convenient.

3. What should I settle with my guide before starting the study?

Agree on the primary biochemical endpoint, diagnostic criteria for type 2 diabetes, definition of glycaemic control, fasting requirements, assay methods, comparison groups and treatment variables to record. Also decide how obesity, hypertension, anaemia, renal dysfunction, diabetes duration and medications that influence the chosen biomarker will be excluded, stratified or adjusted for.

4. Can treated and newly diagnosed patients with type 2 diabetes be analysed together?

They can be included in the same study population only if treatment status is explicitly recorded and handled in the design or analysis. Glucose, insulin, lipid profile, uric acid, vitamin concentrations and renal markers may differ because of medication exposure as well as disease biology. Combining newly diagnosed and long-treated patients without accounting for therapy and duration can therefore obscure the relationship the study intends to measure.

5. What is the difference between a type 2 diabetes biochemistry synopsis and a protocol?

The synopsis presents the research question, rationale, objectives and broad methodology for academic approval. The protocol contains the operational detail needed to reproduce the study, including diagnostic definitions, sample timing, fasting state, medication exposure, assay methods, calculated-index formulae, confounders and statistical analysis. These details are particularly important when biochemical differences may reflect treatment rather than glycaemic status alone.

6. What ethical issues should I address in type 2 diabetes biochemistry studies?

Prospective studies involving children require guardian consent and, from about seven years where appropriate, child assent, although most type 2 diabetes projects in MD Biochemistry involve adults. Record-based studies may seek a waiver of consent when permitted by the ethics committee and when confidentiality safeguards are adequate. Research-only venepuncture should be minimised and any additional blood volume should be explicitly limited according to age and institutional policy. Extra radiation or contrast exposure is not justified for a purely biochemical endpoint. Separate consent is required for identifiable photographs or video. The protocol should also define how clinically important incidental findings such as severe hyperglycaemia, marked hypoglycaemia, severe dyslipidaemia, significant renal dysfunction, major electrolyte disturbance or critical vitamin deficiency will be communicated for clinical review.

7. Why can HbA1c misclassify glycaemic control in a type 2 diabetes study?

HbA1c reflects glycaemic exposure over preceding weeks but also depends on red-cell lifespan. Iron deficiency anaemia may raise HbA1c, while haemolysis or shortened erythrocyte survival may lower it; recent transfusion and some haemoglobin variants can further complicate interpretation. Chronic kidney disease adds additional problems through anaemia, altered erythrocyte turnover and treatment. A study using HbA1c to define good and poor control should therefore prespecify how these conditions will be identified and handled.

8. How is a PhD proposal different from an MD Biochemistry synopsis?

An MD synopsis is usually centred on a focused clinical-biochemical question that can be completed during postgraduate training using available patients and laboratory facilities. A PhD proposal generally requires a broader and more original programme of work, often with mechanistic experiments, longitudinal components or multiple linked objectives. The expected novelty, depth and duration are therefore different.

9. When should I register my type 2 diabetes biochemistry thesis topic?

Registration should follow confirmation that the required patient groups, laboratory assays, treatment information and ethics pathway are available. It should be completed early enough to allow protocol approval and recruitment without relying on data collected before the definitions, sample timing and analytical plan have been finalised.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.